Current Knowledge of Equine Water Treadmill Exercise: What Can We Learn From Human and Canine Studies?

Equine water treadmills (WTs) are increasingly being found in research and therapy centers and private competition yards. However, the programs incorporating WT exercise for training and rehabilitation of horses are mainly based on anecdotal evidence due to the lack of scientific evidence available. This review aims to evaluate what is currently known about WT exercise for horses drawing on what is known from human and canine investigations. Studies of WT exercise have demonstrated that water depth, temperature, and speed have a significant effect on physiological responses in humans. The physiological studies in horses show many similarities to human responses with much evidence demonstrating that WT exercise is an aerobic form of exercise which does not appear to induce improvement in aerobic capacity when used within training programs. Equine and canine studies have shown that water depth can have a significant effect on the biomechanical responses to WT exercise, but little is known about the effect of different speeds at the various water depths. Key areas we would recommend for future research are as follows: how combinations of water depth and speed alter equine biomechanics compared to overland exercise, determination of long-term benefits of WT exercise, and how to use WT for rehabilitation for horses with specific injury.     

Canine T‐Zone Lymphoma: Unique Immunophenotypic Features,Outcome, and Population Characteristics

Background

Canine T‐cell lymphoma (TCL) is clinically and histologically heterogeneous with some forms, such as T‐zone lymphoma (TZL), having an indolent course. Immunophenotyping is an important tool in the classification of TCL in people, and can be equally useful in dogs.

Hypothesis/Objectives

We hypothesized that loss of expression of the CD45 antigen is a specific diagnostic feature of TZL.

Animals

Twenty dogs with concurrent histology and immunophenotyping by flow cytometry were studied in depth. An additional 494 dogs diagnosed by immunophenotyping were used to characterize the population of dogs with this disease.

Methods

Lymph node biopsies from 35 dogs with TCL were classified by 2 pathologists using WHO criteria. Twenty lymph nodes were from dogs with CD45− TCL and 15 were from CD45+ TCL. The pathologists were blinded to the flow cytometry findings. Outcome information was sought for the 20 dogs with CD45− lymphoma, and population characteristics of the additional 494 dogs were described.

Results

All 20 CD45− cases were classified as TZL. The 15 CD45+ cases were classified as aggressive TCL and are described in an accompanying paper. TZL cases had a median survival of 637 days. Examination of 494 additional dogs diagnosed with TZL by immunophenotyping demonstrated that 40% of cases are in Golden Retrievers, are diagnosed at a median age of 10 years, and the majority have lymphadenopathy and lymphocytosis.

Conclusions

TZL has unique immunophenotypic features that can be used for diagnosis.     

What Do We Know About Clodronate Now? A Medical and Veterinary Perspective

There has recently been some controversy over the use of bisphosphonates in horses and some confusion regarding the different classes of bisphosphonates and the differences between the mechanism of actions and effects of each class. This review article explores the different bisphosphonate classes and their different effects and mechanisms of action based on research from both the human and equine veterinary fields. This collaborative review between veterinary surgeons and medical doctors describes the latest use of bisphosphonates in humans and horses, including safety aspects, and allows comparisons to be drawn between the two fields. Potential future uses of bisphosphonates are also discussed.